RxDoctor Payments Data

Lee Bleshoy, NP

Family · Winder, GANPI 1669636767

Payments from drug & device makers

$362in general payments, 2019–2025

Across 20 payments — averaging $18.09 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Corcept Therapeutics$89
  • Exact Sciences$56
  • AbbVie$49
  • GSK$31
  • Sanofi-aventis U.S. LLC$23
  • Dexcom, Inc.$20
  • plus $94 from 6 others

What the payments were for

  • Food & beverage$362100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$362 in reported general payments places this provider in the 45th percentile of 6,258 family providers in Georgia.

See all family providers in Georgia

Medicare billing

Part B allowed, 2024
$487
Medicare patients
24
Services billed
51

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
JardianceEmpagliflozin29$34,691
JanuviaSitagliptin Phosphate23$28,445
XareltoRivaroxaban12$17,647
FarxigaDapagliflozin Propanediol13$16,592
Levemir FlexpenInsulin Detemir14$5,123
Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog12$3,937
Lantus SolostarInsulin Glargine,hum.Rec.Anlog23$2,851
Atorvastatin Calcium229$1,311
Amlodipine Besylate232$979
Omeprazole77$809
Glipizide ErGlipizide47$804
Levothyroxine Sodium80$667
Gabapentin50$657
Metoprolol Succinate74$621
Albuterol Sulfate HfaAlbuterol Sulfate28$619

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Johnson & JohnsonXarelto$12$17,64712 claims
AstraZenecaFarxiga$14$16,59213 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 45th percentile of 6,258 family providers in Georgia.

Other family in Winder

See the full list for Georgia

Where these figures come from

Is this you, or does something look wrong? →